P.A.W. Capital Corp grew its position in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 25.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,000,000 shares of the company's stock after purchasing an additional 400,000 shares during the period. DocGo makes up about 13.1% of P.A.W. Capital Corp's investment portfolio, making the stock its 3rd largest position. P.A.W. Capital Corp owned approximately 1.96% of DocGo worth $5,280,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Invesco Ltd. boosted its holdings in DocGo by 1.3% in the fourth quarter. Invesco Ltd. now owns 177,953 shares of the company's stock valued at $755,000 after purchasing an additional 2,312 shares during the last quarter. Summit Investment Advisors Inc. raised its position in shares of DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after purchasing an additional 2,968 shares in the last quarter. Rhumbline Advisers boosted its stake in shares of DocGo by 4.5% during the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company's stock valued at $605,000 after buying an additional 6,204 shares during the last quarter. Victory Capital Management Inc. grew its position in shares of DocGo by 12.3% during the fourth quarter. Victory Capital Management Inc. now owns 57,649 shares of the company's stock worth $244,000 after buying an additional 6,300 shares in the last quarter. Finally, MetLife Investment Management LLC increased its stake in shares of DocGo by 12.1% in the fourth quarter. MetLife Investment Management LLC now owns 60,245 shares of the company's stock worth $255,000 after buying an additional 6,517 shares during the last quarter. 56.44% of the stock is owned by institutional investors and hedge funds.
DocGo Stock Up 1.0%
DCGO stock traded up $0.02 during trading on Friday, hitting $1.59. 344,412 shares of the company's stock traded hands, compared to its average volume of 767,313. The stock has a market capitalization of $161.64 million, a price-to-earnings ratio of -79.25 and a beta of 0.97. DocGo Inc. has a 52 week low of $1.23 and a 52 week high of $5.68. The stock has a fifty day moving average price of $1.64 and a two-hundred day moving average price of $2.98.
DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08). The business had revenue of $96.03 million during the quarter, compared to analyst estimates of $104.25 million. DocGo had a negative net margin of 0.12% and a positive return on equity of 2.52%. As a group, equities research analysts expect that DocGo Inc. will post 0.25 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of research firms have commented on DCGO. Needham & Company LLC reduced their price objective on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Canaccord Genuity Group reaffirmed a "hold" rating and set a $1.45 price target (down previously from $5.00) on shares of DocGo in a research report on Monday, May 12th. Finally, BTIG Research downgraded DocGo from a "buy" rating to a "neutral" rating in a research note on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, DocGo currently has a consensus rating of "Moderate Buy" and an average price target of $3.56.
Read Our Latest Stock Report on DocGo
DocGo Company Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Articles

Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.